A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT05878769 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05878769
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2027-06-30
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.